Literature DB >> 24198867

Atrial Fibrillation and Race - A Contemporary Review.

Michael K D Amponsah1, Emelia J Benjamin, Jared W Magnani.   

Abstract

Atrial fibrillation (AF) is the most commonly encountered clinical arrhythmia and is associated with adverse outcomes and increased healthcare costs. Racial variations in AF are recognized yet poorly understood. In this review we summarize racial differences in AF epidemiology, risk factors, genetics, and outcomes. We identify novel risk factors, inflammatory mediators and biomarkers associated with AF, which have had limited study in racial and ethnic minorities. We describe the mismatch between risk factor burden and AF. We highlight the limited participation of minorities in trials for AF management and stroke prevention that contrasts with observed racial variability in anticoagulation efficacy and practice. Throughout we provide specific strategies for future directions to address gaps in the epidemiology of racial differences and to meet identified racial disparities. We specifically identify areas for further research. We conclude that addressing disparities in prevention and healthcare resource allocation will likely improve AF-related outcomes in minorities.

Entities:  

Keywords:  African-American; Atrial fibrillation; Epidemiology; Ethnicity; Race

Year:  2013        PMID: 24198867      PMCID: PMC3815541          DOI: 10.1007/s12170-013-0327-8

Source DB:  PubMed          Journal:  Curr Cardiovasc Risk Rep        ISSN: 1932-9520


  94 in total

1.  European ancestry as a risk factor for atrial fibrillation in African Americans.

Authors:  Gregory M Marcus; Alvaro Alonso; Carmen A Peralta; Guillaume Lettre; Eric Vittinghoff; Steven A Lubitz; Ervin R Fox; Yamini S Levitzky; Reena Mehra; Kathleen F Kerr; Rajat Deo; Nona Sotoodehnia; Meggie Akylbekova; Patrick T Ellinor; Dina N Paltoo; Elsayed Z Soliman; Emelia J Benjamin; Susan R Heckbert
Journal:  Circulation       Date:  2010-11-16       Impact factor: 29.690

2.  Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation.

Authors:  Apoor S Gami; Dave O Hodge; Regina M Herges; Eric J Olson; Jiri Nykodym; Tomas Kara; Virend K Somers
Journal:  J Am Coll Cardiol       Date:  2007-01-22       Impact factor: 24.094

3.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study.

Authors:  A Ott; M M Breteler; M C de Bruyne; F van Harskamp; D E Grobbee; A Hofman
Journal:  Stroke       Date:  1997-02       Impact factor: 7.914

4.  Racial variations in quality of care and outcomes in an ambulatory heart failure cohort.

Authors:  Anita Deswal; Nancy J Petersen; Diana L Urbauer; Steven M Wright; Rebecca Beyth
Journal:  Am Heart J       Date:  2006-08       Impact factor: 4.749

5.  Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

Authors:  Louise S Jenkins; Michael Brodsky; Eleanor Schron; Mina Chung; Thomas Rocco; Ellis Lader; Martha Constantine; Robert Sheppard; Donald Holmes; Donna Mateski; Liz Floden; Marilyn Prasun; H Leon Greene; Lynn Shemanski
Journal:  Am Heart J       Date:  2005-01       Impact factor: 4.749

6.  Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial.

Authors:  David Bush; Lisa W Martin; Robert Leman; Mary Chandler; L Julian Haywood
Journal:  J Natl Med Assoc       Date:  2006-03       Impact factor: 1.798

7.  The influence of ethnicity on warfarin dosage requirement.

Authors:  Mai-Trang N Dang; Julie Hambleton; Steven R Kayser
Journal:  Ann Pharmacother       Date:  2005-04-26       Impact factor: 3.154

Review 8.  Different aspects of atrial fibrillation genetics.

Authors:  Ahmet Okay Caglayan
Journal:  Interact Cardiovasc Thorac Surg       Date:  2010-08-09

9.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

10.  N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study.

Authors:  Kristen K Patton; Patrick T Ellinor; Susan R Heckbert; Robert H Christenson; Christopher DeFilippi; John S Gottdiener; Richard A Kronmal
Journal:  Circulation       Date:  2009-10-19       Impact factor: 29.690

View more
  16 in total

1.  Effect of race on outcomes (stroke and death) in patients >65 years with atrial fibrillation.

Authors:  Rajesh Kabra; Peter Cram; Saket Girotra; Mary Vaughan Sarrazin
Journal:  Am J Cardiol       Date:  2015-04-16       Impact factor: 2.778

2.  Impact of Race on Outcome of Patients Undergoing Rhythm Control of Atrial Fibrillation.

Authors:  Asad F Durrani; Siva Soma; Andrew D Althouse; George Leef; Dingxin Qin; Samir Saba
Journal:  J Immigr Minor Health       Date:  2018-02

3.  Impact of race and gender on clinical outcomes of catheter ablation in patients with atrial fibrillation.

Authors:  Abdallah Bukari; Hemal Nayak; Zaid Aziz; Amrish Deshmukh; Roderick Tung; Cevher Ozcan
Journal:  Pacing Clin Electrophysiol       Date:  2017-09-20       Impact factor: 1.976

4.  Socioeconomic status and the development of atrial fibrillation in Hispanics, African Americans and non-Hispanic whites.

Authors:  Eric Shulman; Faraj Kargoli; Philip Aagaard; Ethan Hoch; Luigi Di Biase; John Fisher; Jay Gross; Soo Kim; Kevin J Ferrick; Andrew Krumerman
Journal:  Clin Cardiol       Date:  2017-06-09       Impact factor: 2.882

5.  Race and Socioeconomic Status Regulate Lifetime Risk of Atrial Fibrillation.

Authors:  Mark D McCauley; Dawood Darbar
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-07

Review 6.  Screening for Atrial Fibrillation in Community and Primary CareSettings: A Scoping Review.

Authors:  Emma Canty; Claire MacGilchrist; Wael Tawfick; Caroline McIntosh
Journal:  J Atr Fibrillation       Date:  2021-02-28

7.  Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation.

Authors:  Wesley T O'Neal; Aniqa B Alam; Pratik B Sandesara; J'Neka S Claxton; Richard F MacLehose; Lin Y Chen; Lindsay G S Bengtson; Alanna M Chamberlain; Faye L Norby; Pamela L Lutsey; Alvaro Alonso
Journal:  PLoS One       Date:  2019-09-04       Impact factor: 3.240

8.  Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Jared W Magnani; Faye L Norby; Sunil K Agarwal; Elsayed Z Soliman; Lin Y Chen; Laura R Loehr; Alvaro Alonso
Journal:  JAMA Cardiol       Date:  2016-07-01       Impact factor: 14.676

9.  Using increased trust in medical researchers to increase minority recruitment: The RECRUIT cluster randomized clinical trial.

Authors:  Barbara C Tilley; Arch G Mainous; Rossybelle P Amorrortu; M Diane McKee; Daniel W Smith; Ruosha Li; Stacia M DeSantis; Sally W Vernon; Gary Koch; Marvella E Ford; Vanessa Diaz; Jennifer Alvidrez
Journal:  Contemp Clin Trials       Date:  2021-07-30       Impact factor: 2.261

Review 10.  Atrial fibrillation in the Indigenous populations of Australia, Canada, New Zealand, and the United States: a systematic scoping review.

Authors:  Judith M Katzenellenbogen; John A Woods; Tiew-Hwa Katherine Teng; Sandra C Thompson
Journal:  BMC Cardiovasc Disord       Date:  2015-08-13       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.